Tag: systemic therapy

Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx^® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsSystemic therapy

Bitcoin Swift Presale 2025 Nears Stage 2: Real Utility, AI-Powered Blockchain

Media Mister Marks 13 Years of Supporting Creators in the Digital Age

As XRP Crosses $200 Billion Market Cap, HashJ Expands Support for Scalable XRP & Dogecoin Contract Rewards

Tag: systemic therapy

Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us